Tianjin TEDA Biomedical Engineering Co. Ltd.

  • Market Cap: N/A
  • Industry: Chemicals & Petrochemicals
  • ISIN: CNE1000004H7
HKD
0.33
-0.08 (-18.52%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Net Sales has grown by an annual rate of -6.24% and Operating profit at -8.63% over the last 5 years

 
2

The company declared negative results in Dec'24 after positive results in Jun'24

3

With ROE of 26.18%, it has a Very Expensive valuation with a 26.86 Price to Book Value

4

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Chemicals & Petrochemicals

stock-summary
Market cap

HKD 438 Million ()

stock-summary
P/E

103.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.51

stock-summary
Return on Equity

5.83%

stock-summary
Price to Book

4.14

Revenue and Profits:
Net Sales:
99 Million
(Quarterly Results - Dec 2016)
Net Profit:
-8 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-38.89%
0%
-38.89%
6 Months
13.79%
0%
13.79%
1 Year
334.21%
0%
334.21%
2 Years
323.08%
0%
323.08%
3 Years
107.55%
0%
107.55%
4 Years
50.0%
0%
50.0%
5 Years
233.33%
0%
233.33%

Tianjin TEDA Biomedical Engineering Co. Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-6.24%
EBIT Growth (5y)
-8.63%
EBIT to Interest (avg)
5.03
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
3.87
Sales to Capital Employed (avg)
2.73
Tax Ratio
32.95%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3,418.30%
ROE (avg)
1,933.92%

Valuation key factors

Factor
Value
P/E Ratio
103
Industry P/E
Price to Book Value
26.86
EV to EBIT
37.66
EV to EBITDA
24.70
EV to Capital Employed
6.31
EV to Sales
1.59
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
16.76%
ROE (Latest)
26.18%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Tianjin TEDA Biomedical Engineering Co. Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -4.98% vs -6.33% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -240.50% vs 55.84% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "417.90",
          "val2": "439.80",
          "chgp": "-4.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-23.70",
          "val2": "-10.40",
          "chgp": "-127.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.00",
          "val2": "5.70",
          "chgp": "-12.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.60",
          "val2": "17.00",
          "chgp": "-115.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-41.20",
          "val2": "-12.10",
          "chgp": "-240.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-80.40%",
          "val2": "-52.90%",
          "chgp": "-2.75%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
417.90
439.80
-4.98%
Operating Profit (PBDIT) excl Other Income
-23.70
-10.40
-127.88%
Interest
5.00
5.70
-12.28%
Exceptional Items
-2.60
17.00
-115.29%
Consolidate Net Profit
-41.20
-12.10
-240.50%
Operating Profit Margin (Excl OI)
-80.40%
-52.90%
-2.75%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -4.98% vs -6.33% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -240.50% vs 55.84% in Dec 2023

stock-summaryCompany CV
About Tianjin TEDA Biomedical Engineering Co. Ltd. stock-summary
stock-summary
Tianjin TEDA Biomedical Engineering Co. Ltd.
Chemicals & Petrochemicals
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available